龍岡 久登

Last Update: 2020/07/28 11:15:07

Print

Name(Kanji/Kana/Abecedarium Latinum)
龍岡 久登/タツオカ ヒサト/Tatsuoka, Hisato
Primary Affiliation(Org1/Job title)
Kyoto University Hospital/Program-Specific Assistant Professor
researchmap URL
https://researchmap.jp/00511032
Research Topics
(Japanese)
膵β細胞のバイオロジー
Overview of the research
(Japanese)
膵β細胞の再生に関わる分子機構の解析
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Yuki Yamauchi, Yuzo Kodama, Masahiro Shiokawa, Nobuyuki Kakiuchi, Saiko Marui, Takeshi Kuwada, Yuko Sogabe, Teruko Tomono, Atsushi Mima, Toshihiro Morita, Tomoaki Matsumori, Tatsuki Ueda, Motoyuki Tsuda, Yoshihiro Nishikawa, Katsutoshi Kuriyama, Yojiro Sakuma, Yuji Ota, Takahisa Maruno, Norimitsu Uza, Atsuhiro Masuda, Hisato Tatsuoka, Daisuke Yabe, Sachiko Minamiguchi, Toshihiko Masui, Nobuya Inagaki, Shinji Uemoto, Tsutomu Chiba, Hiroshi Seno Yuki Yamauchi, Yuzo Kodama, Masahiro Shiokawa, Nobuyuki Kakiuchi, Saiko Marui, Takeshi Kuwada, Yuko Sogabe, Teruko Tomono, Atsushi Mima, Toshihiro Morita, Tomoaki Matsumori, Tatsuki Ueda, Motoyuki Tsuda, Yoshihiro Nishikawa, Katsutoshi Kuriyama, Yojiro Sakuma, Yuji Ota, Takahisa Maruno, Norimitsu Uza, Atsuhiro Masuda, Hisato Tatsuoka, Daisuke Yabe, Sachiko Minamiguchi, Toshihiko Masui, Nobuya Inagaki, Shinji Uemoto, Tsutomu Chiba, Hiroshi Seno Rb and p53 execute distinct roles in the development of pancreatic neuroendocrine tumors Rb and p53 execute distinct roles in the development of pancreatic neuroendocrine tumors Rb and p53 execute distinct roles in the development of pancreatic neuroendocrine tumors Cancer Research, canres.2232.2019-canres.2232.2019 , canres.2232.2019-canres.2232.2019 Cancer Research, canres.2232.2019-canres.2232.2019 2020/06/26 Refereed Research paper(scientific journal) Disclose to all
Usui R, Yabe D, Fauzi M, Goto H, Botagarova A, Tokumoto S, Tatsuoka H, Tahara Y, Kobayashi S, Manabe T, Baba Y, Kurosaki T, Herrera PL, Ogura M, Nagashima K, Inagaki N Usui R, Yabe D, Fauzi M, Goto H, Botagarova A, Tokumoto S, Tatsuoka H, Tahara Y, Kobayashi S, Manabe T, Baba Y, Kurosaki T, Herrera PL, Ogura M, Nagashima K, Inagaki N Usui R, Yabe D, Fauzi M, Goto H, Botagarova A, Tokumoto S, Tatsuoka H, Tahara Y, Kobayashi S, Manabe T, Baba Y, Kurosaki T, Herrera PL, Ogura M, Nagashima K, Inagaki N GPR40 activation initiates store operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells. GPR40 activation initiates store operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells. GPR40 activation initiates store operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells. Scientific Reports, 9, 1, 15562 Scientific Reports, 9, 1, 15562 Scientific Reports, 9, 1, 15562 2019/10 Refereed English Research paper(scientific journal) Disclose to all
Yanyan Liu, Shin Ichi Harashima, Yu Wang, Kazuyo Suzuki, Shinsuke Tokumoto, Ryota Usui, Hisato Tatsuoka, Daisuke Tanaka, Daisuke Yabe, Norio Harada, Yoshitaka Hayashi, Nobuya Inagaki Yanyan Liu, Shin Ichi Harashima, Yu Wang, Kazuyo Suzuki, Shinsuke Tokumoto, Ryota Usui, Hisato Tatsuoka, Daisuke Tanaka, Daisuke Yabe, Norio Harada, Yoshitaka Hayashi, Nobuya Inagaki Yanyan Liu, Shin Ichi Harashima, Yu Wang, Kazuyo Suzuki, Shinsuke Tokumoto, Ryota Usui, Hisato Tatsuoka, Daisuke Tanaka, Daisuke Yabe, Norio Harada, Yoshitaka Hayashi, Nobuya Inagaki Sphingosine kinase 1–interacting protein is a dual regulator of insulin and incretin secretion Sphingosine kinase 1–interacting protein is a dual regulator of insulin and incretin secretion Sphingosine kinase 1–interacting protein is a dual regulator of insulin and incretin secretion FASEB Journal, 33, 5, 6239-6253 FASEB Journal, 33, 5, 6239-6253 FASEB Journal, 33, 5, 6239-6253 2019/05/01 Refereed Research paper(scientific journal) Disclose to all
Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D Kuwata H, Okamoto S, Seino Yus, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Yut, Yabe D Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes Relationship between deterioration of HbA1c-lowering effects in DPP-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes J Diabetes Investig, 9, 5, 1153-1158 J Diabetes Investig, 9, 5, 1153-1158 J Diabetes Investig, 9, 5, 1153-1158 2018/09 Refereed English Research paper(scientific journal) Disclose to all
Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Hitoshi Kuwata, Saki Okamoto, Yusuke Seino, Kenta Murotani, Hisato Tatsuoka, Ryota Usui, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes. Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes. Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes. Journal of diabetes investigation, 9, 5, 1153-1158 Journal of diabetes investigation, 9, 5, 1153-1158 Journal of diabetes investigation, 9, 5, 1153-1158 2018/09 Refereed English Disclose to all
Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D Usui R, Sakuramachi Y, Seino Yus, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Yut, Yabe D Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation. Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation. Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target one year after initiation. J Diabetes Investig, 9, 4, 822-830 J Diabetes Investig, 9, 4, 822-830 J Diabetes Investig, 9, 4, 822-830 2018/07 Refereed English Research paper(scientific journal) Disclose to all
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation. Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation. Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation. Journal of diabetes investigation, 9, 4, 822-830 Journal of diabetes investigation, 9, 4, 822-830 Journal of diabetes investigation, 9, 4, 822-830 2018/07 Refereed English Disclose to all
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation. Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after init Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation. Journal of diabetes investigation, 9, 4, 981-983 Journal of diabetes investigation, 9, 4, 981-983 Journal of diabetes investigation, 9, 4, 981-983 2018/07 Refereed English Disclose to all
Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima Kasane Ogura, Masahito Ogura, Toshihiko Shoji, Yuichi Sato, Yumiko Tahara, Gen Yamano, Hiroki Sato, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Muka, Shimpei Fujimoto, Nobuya Inagaki, Kazuaki Nagashima Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865 JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865 JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 64, 46, 8857-8865 2016/11 Refereed English Research paper(scientific journal) Disclose to all
Hiroki Sato, Kazuaki Nagashima, Masahito Ogura, Yuichi Sato, Yumiko Tahara, Kasane Ogura, Gen Yamano, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Mukai, Shimpei Fujimoto, Nobuya Inagaki Hiroki Sato, Kazuaki Nagashima, Masahito Ogura, Yuichi Sato, Yumiko Tahara, Kasane Ogura, Gen Yamano, Kazu Sugizaki, Naotaka Fujita, Hisato Tatsuoka, Ryota Usui, Eri Mukai, Shimpei Fujimoto, Nobuya Inagaki Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic -cells Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic β-cells. Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic -cells JOURNAL OF DIABETES INVESTIGATION, 7, 2, 171-178 Journal of diabetes investigation, 7, 2, 171-178 JOURNAL OF DIABETES INVESTIGATION, 7, 2, 171-178 2016/03 Refereed English Research paper(scientific journal) Disclose to all
K. Mori, Y. Iwasaki, Y. Kawasaki-Ogita, S. Honjo, Y. Hamamoto, H. Tatsuoka, K. Fujimoto, H. Ikeda, Y. Wada, Y. Takahashi, J. Takahashi, H. Koshiyama K. Mori, Y. Iwasaki, Y. Kawasaki-Ogita, S. Honjo, Y. Hamamoto, H. Tatsuoka, K. Fujimoto, H. Ikeda, Y. Wada, Y. Takahashi, J. Takahashi, H. Koshiyama K. Mori, Y. Iwasaki, Y. Kawasaki-Ogita, S. Honjo, Y. Hamamoto, H. Tatsuoka, K. Fujimoto, H. Ikeda, Y. Wada, Y. Takahashi, J. Takahashi, H. Koshiyama Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: Correlation with serum IGF-I levels Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: Correlation with serum IGF-I levels Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: Correlation with serum IGF-I levels JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 36, 10, 853-859 JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 36, 10, 853-859 JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 36, 10, 853-859 2013/11 Refereed English Research paper(scientific journal) Disclose to all
K. Fujimoto, S. Honjo, H. Tatsuoka, Y. Hamamoto, Y. Kawasaki, A. Matsuoka, H. Ikeda, Y. Wada, H. Sasano, H. Koshiyama K. Fujimoto, S. Honjo, H. Tatsuoka, Y. Hamamoto, Y. Kawasaki, A. Matsuoka, H. Ikeda, Y. Wada, H. Sasano, H. Koshiyama K. Fujimoto, S. Honjo, H. Tatsuoka, Y. Hamamoto, Y. Kawasaki, A. Matsuoka, H. Ikeda, Y. Wada, H. Sasano, H. Koshiyama Primary aldosteronism associated with subclinical Cushing syndrome Primary aldosteronism associated with subclinical Cushing syndrome Primary aldosteronism associated with subclinical Cushing syndrome JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 36, 8, 564-567 JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 36, 8, 564-567 JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 36, 8, 564-567 2013/09 Refereed English Research paper(scientific journal) Disclose to all
The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes. The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes. The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes. Japanese clinical medicine Japanese clinical medicine Japanese clinical medicine 2013/05 Refereed Disclose to all
Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Kanako Mori, Hisato Tatsuoka, Atsuko Matsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Kanako Mori, Hisato Tatsuoka, Atsuko Matsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Kanako Mori, Hisato Tatsuoka, Atsuko Matsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes DIABETES RESEARCH AND CLINICAL PRACTICE, 99, 2, E21-E23 DIABETES RESEARCH AND CLINICAL PRACTICE, 99, 2, E21-E23 DIABETES RESEARCH AND CLINICAL PRACTICE, 99, 2, E21-E23 2013/02 Refereed English Research paper(scientific journal) Disclose to all
Male gonadotroph adenoma: report of three cases and a review of the literature. Male gonadotroph adenoma: report of three cases and a review of the literature. Male gonadotroph adenoma: report of three cases and a review of the literature. Internal medicine (Tokyo, Japan) Internal medicine (Tokyo, Japan) Internal medicine (Tokyo, Japan) 2013/01 Refereed Disclose to all
Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Hiroki Ikeda, Kanako Mori, Kanta Fujimoto, Hisato Tatsuoka, Yorihiro Iwasaki, Kazuhiro Nomura, Yoshiharu Wada, Hiroki Koshiyama Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Hiroki Ikeda, Kanako Mori, Kanta Fujimoto, Hisato Tatsuoka, Yorihiro Iwasaki, Kazuhiro Nomura, Yoshiharu Wada, Hiroki Koshiyama Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Hiroki Ikeda, Kanako Mori, Kanta Fujimoto, Hisato Tatsuoka, Yorihiro Iwasaki, Kazuhiro Nomura, Yoshiharu Wada, Hiroki Koshiyama Relationship between Telmisartan Dose and Glycaemic Control in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension A Retrospective Study Relationship between Telmisartan Dose and Glycaemic Control in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension A Retrospective Study Relationship between Telmisartan Dose and Glycaemic Control in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension A Retrospective Study CLINICAL DRUG INVESTIGATION, 32, 9, 577-582 CLINICAL DRUG INVESTIGATION, 32, 9, 577-582 CLINICAL DRUG INVESTIGATION, 32, 9, 577-582 2012 Refereed English Research paper(scientific journal) Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
劉 彦言, 原島 伸一, 王 宇, 鈴木 和代, 徳本 信介, 臼井 亮太, 龍岡 久登, 田中 大祐, 矢部 大介, 原田 範雄, 林 良敬, 稲垣 暢也 劉 彦言, 原島 伸一, 王 宇, 鈴木 和代, 徳本 信介, 臼井 亮太, 龍岡 久登, 田中 大祐, 矢部 大介, 原田 範雄, 林 良敬, 稲垣 暢也 劉 彦言, 原島 伸一, 王 宇, 鈴木 和代, 徳本 信介, 臼井 亮太, 龍岡 久登, 田中 大祐, 矢部 大介, 原田 範雄, 林 良敬, 稲垣 暢也 Sphingosine kinase 1-interacting proteinはインスリン及びインクレチン分泌の双方の制御因子である Sphingosine kinase 1-interacting proteinはインスリン及びインクレチン分泌の双方の制御因子である Sphingosine kinase 1-interacting proteinはインスリン及びインクレチン分泌の双方の制御因子である 日本臨床分子医学会学術総会プログラム・抄録集, 56回, 69-69 日本臨床分子医学会学術総会プログラム・抄録集, 56回, 69-69 日本臨床分子医学会学術総会プログラム・抄録集, 56回, 69-69 2019/04 Japanese Disclose to all
矢部 大介, 桑田 仁司, 岡本 紗希, 室谷 健太, 清野 祐介, 臼井 亮太, 龍岡 久登, 浜本 芳之, 黒瀬 健, 清野 裕 矢部 大介, 桑田 仁司, 岡本 紗希, 室谷 健太, 清野 祐介, 臼井 亮太, 龍岡 久登, 浜本 芳之, 黒瀬 健, 清野 裕 矢部 大介, 桑田 仁司, 岡本 紗希, 室谷 健太, 清野 祐介, 臼井 亮太, 龍岡 久登, 浜本 芳之, 黒瀬 健, 清野 裕 DPP-4阻害薬の長期有効性と食習慣 日本人2型糖尿病患者におけるメトホルミンとの後ろ向き比較解析 DPP-4阻害薬の長期有効性と食習慣 日本人2型糖尿病患者におけるメトホルミンとの後ろ向き比較解析 DPP-4阻害薬の長期有効性と食習慣 日本人2型糖尿病患者におけるメトホルミンとの後ろ向き比較解析 日本内分泌学会雑誌, 94, 1, 337-337 日本内分泌学会雑誌, 94, 1, 337-337 日本内分泌学会雑誌, 94, 1, 337-337 2018/04 Japanese Disclose to all
龍岡久登, 矢部大介 龍岡久登, 矢部大介 海外文献紹介 p16(Ink4a)-Induced Senescence of Pancreatic Beta Cells Enhances Insulin Secretion 海外文献紹介 p16(Ink4a)-Induced Senescence of Pancreatic Beta Cells Enhances Insulin Secretion Diabetes Frontier, 27, 5 Diabetes Frontier, 27, 5 , 27, 5 2016/10 Japanese Article, review, commentary, editorial, etc.(trade magazine, newspaper, online media) Disclose to all
小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 杉崎和, 臼井亮太, 龍岡久登, 佐藤雄一, 山野言, 佐藤広規, 小倉雅仁, 稲垣暢也 小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 杉崎和, 臼井亮太, 龍岡久登, 佐藤雄一, 山野言, 佐藤広規, 小倉雅仁, 稲垣暢也 小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 杉崎和, 臼井亮太, 龍岡久登, 佐藤雄一, 山野言, 佐藤広規, 小倉雅仁, 稲垣暢也 林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果とその機序の検討 林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果とその機序の検討 林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果とその機序の検討 糖尿病(Web), 59, Suppl, S.333(J‐STAGE) 糖尿病(Web), 59, Suppl, S.333(J‐STAGE) 糖尿病(Web), 59, Suppl, S.333(J‐STAGE) 2016 Japanese Disclose to all
小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 稲垣暢也 小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 稲垣暢也 小倉かさね, 長嶋一昭, 庄司俊彦, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 稲垣暢也 林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果の検討 林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果の検討 林檎由来プロシアニジン類の重合度の違いによる抗糖尿病効果の検討 糖尿病, 58, Supplement 1, S.446 糖尿病, 58, Supplement 1, S.446 糖尿病, 58, Supplement 1, S.446 2015/04/25 Japanese Disclose to all
小倉かさね, 長嶋一昭, 庄司俊彦, 佐藤雄一, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 向英里, 藤本新平, 稲垣暢也 小倉かさね, 長嶋一昭, 庄司俊彦, 佐藤雄一, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 向英里, 藤本新平, 稲垣暢也 小倉かさね, 長嶋一昭, 庄司俊彦, 佐藤雄一, 田原裕美子, 山野言, 佐藤広規, 杉崎和, 臼井亮太, 龍岡久登, 小倉雅仁, 向英里, 藤本新平, 稲垣暢也 林檎由来プロシアニジン類長期投与によるob/obマウスにおけるインスリン抵抗性改善機序の検討 林檎由来プロシアニジン類長期投与によるob/obマウスにおけるインスリン抵抗性改善機序の検討 林檎由来プロシアニジン類長期投与によるob/obマウスにおけるインスリン抵抗性改善機序の検討 日本病態栄養学会誌, 18, Supplement, S.88 日本病態栄養学会誌, 18, Supplement, S.88 日本病態栄養学会誌, 18, Supplement, S.88 2014/12/10 Japanese Disclose to all
S. Honjo, Y. Hamamoto, A. Matsuoka, H. Tatsuoka, K. Fujimoto, Y. Shibayama, S. Tokumoto, E. Yamaguchi, E. Okamura, Y. Wada, H. Ikeda, Y. Kawasaki-Ogita, J. Fujikawa, H. Koshiyama, A. Hamasaki S. Honjo, Y. Hamamoto, A. Matsuoka, H. Tatsuoka, K. Fujimoto, Y. Shibayama, S. Tokumoto, E. Yamaguchi, E. Okamura, Y. Wada, H. Ikeda, Y. Kawasaki-Ogita, J. Fujikawa, H. Koshiyama, A. Hamasaki S. Honjo, Y. Hamamoto, A. Matsuoka, H. Tatsuoka, K. Fujimoto, Y. Shibayama, S. Tokumoto, E. Yamaguchi, E. Okamura, Y. Wada, H. Ikeda, Y. Kawasaki-Ogita, J. Fujikawa, H. Koshiyama, A. Hamasaki INVESTIGATION OF UPPER GASTROINTESTINAL SYMPTOMS IN JAPANESE PATIENTS WITH DIABETES INVESTIGATION OF UPPER GASTROINTESTINAL SYMPTOMS IN JAPANESE PATIENTS WITH DIABETES INVESTIGATION OF UPPER GASTROINTESTINAL SYMPTOMS IN JAPANESE PATIENTS WITH DIABETES DIABETES RESEARCH AND CLINICAL PRACTICE, 106, S174-S175 DIABETES RESEARCH AND CLINICAL PRACTICE, 106, S174-S175 DIABETES RESEARCH AND CLINICAL PRACTICE, 106, S174-S175 2014/11 English Research paper, summary (international conference) Disclose to all
Y. Wada, Y. Hamamoto, S. Honjo, K. Fujimoto, H. Tatsuoka, A. Matsuoka, H. Ikeda, J. Fujikawa, H. Koshiyama Y. Wada, Y. Hamamoto, S. Honjo, K. Fujimoto, H. Tatsuoka, A. Matsuoka, H. Ikeda, J. Fujikawa, H. Koshiyama Y. Wada, Y. Hamamoto, S. Honjo, K. Fujimoto, H. Tatsuoka, A. Matsuoka, H. Ikeda, J. Fujikawa, H. Koshiyama Enhanced glucose-lowering effect of dipeptidyl peptidase-4 inhibitor in subjects with type 2 diabetes who have a history of gastrectomy Enhanced glucose-lowering effect of dipeptidyl peptidase-4 inhibitor in subjects with type 2 diabetes who have a history of gastrectomy Enhanced glucose-lowering effect of dipeptidyl peptidase-4 inhibitor in subjects with type 2 diabetes who have a history of gastrectomy DIABETOLOGIA, 57, S359-S360 DIABETOLOGIA, 57, S359-S360 DIABETOLOGIA, 57, S359-S360 2014/09 English Research paper, summary (international conference) Disclose to all
Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Hisato Tatsuoka, Shinsuke Tokumoto, Rieko Yamaguchi, Yui Shibayama, Emi Okamura, Yoshiharu Wada, Hiroki Ikeda, Hiroyuki Koshiyama Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Hisato Tatsuoka, Shinsuke Tokumoto, Rieko Yamaguchi, Yui Shibayama, Emi Okamura, Yoshiharu Wada, Hiroki Ikeda, Hiroyuki Koshiyama Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Hisato Tatsuoka, Shinsuke Tokumoto, Rieko Yamaguchi, Yui Shibayama, Emi Okamura, Yoshiharu Wada, Hiroki Ikeda, Hiroyuki Koshiyama Insulin Degludec Improved Glycemic Control without Increasing Hypoglycemia in Patients with Type 1 Diabetes Insulin Degludec Improved Glycemic Control without Increasing Hypoglycemia in Patients with Type 1 Diabetes Insulin Degludec Improved Glycemic Control without Increasing Hypoglycemia in Patients with Type 1 Diabetes DIABETES, 63, A237-A237 DIABETES, 63, A237-A237 DIABETES, 63, A237-A237 2014/06 English Research paper, summary (international conference) Disclose to all
Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Hisato Tatsuoka, Shinsuke Tokumoto, Yoshiharu Wada, Hiroki Ikeda, Hiroyuki Koshiyama Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Hisato Tatsuoka, Shinsuke Tokumoto, Yoshiharu Wada, Hiroki Ikeda, Hiroyuki Koshiyama Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Hisato Tatsuoka, Shinsuke Tokumoto, Yoshiharu Wada, Hiroki Ikeda, Hiroyuki Koshiyama Enhanced Response of Incretin Hormones to Oral Glucose Tolerance Test in Patients with Crohn's Disease and with Ulcerative Colitis Enhanced Response of Incretin Hormones to Oral Glucose Tolerance Test in Patients with Crohn's Disease and with Ulcerative Colitis Enhanced Response of Incretin Hormones to Oral Glucose Tolerance Test in Patients with Crohn's Disease and with Ulcerative Colitis ENDOCRINE REVIEWS, 35, 3 ENDOCRINE REVIEWS, 35, 3 ENDOCRINE REVIEWS, 35, 3 2014/06 English Research paper, summary (international conference) Disclose to all
Hisato Tatsuoka, Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Atsuko Matsuoka, Yui Shibayama, Shinsuke Tokumoto, Eriko Yamaguchi, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Hisato Tatsuoka, Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Atsuko Matsuoka, Yui Shibayama, Shinsuke Tokumoto, Eriko Yamaguchi, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Hisato Tatsuoka, Yoshiyuki Hamamoto, Sachiko Honjo, Kanta Fujimoto, Atsuko Matsuoka, Yui Shibayama, Shinsuke Tokumoto, Eriko Yamaguchi, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Teneligliptin Improved Postprandial Hyperglycemia without Severe Hypoglycemia and Increasing NT-proBNP in Japanese Patients with Type 2 Diabetes and Chronic Renal Failure Teneligliptin Improved Postprandial Hyperglycemia without Severe Hypoglycemia and Increasing NT-proBNP in Japanese Patients with Type 2 Diabetes and Chronic Renal Failure Teneligliptin Improved Postprandial Hyperglycemia without Severe Hypoglycemia and Increasing NT-proBNP in Japanese Patients with Type 2 Diabetes and Chronic Renal Failure DIABETES, 63, A612-A612 DIABETES, 63, A612-A612 DIABETES, 63, A612-A612 2014/06 English Research paper, summary (international conference) Disclose to all
K. Fujimoto, Y. Hamamoto, S. Honjo, H. Tatsuoka, A. Matsuoka, Y. Wada, H. Ikeda, J. Fujikawa, I. Saito, H. Koshiyama K. Fujimoto, Y. Hamamoto, S. Honjo, H. Tatsuoka, A. Matsuoka, Y. Wada, H. Ikeda, J. Fujikawa, I. Saito, H. Koshiyama K. Fujimoto, Y. Hamamoto, S. Honjo, H. Tatsuoka, A. Matsuoka, Y. Wada, H. Ikeda, J. Fujikawa, I. Saito, H. Koshiyama Pioglitazone increases the risk of diabetic macular oedema in patients with type 2 diabetes Pioglitazone increases the risk of diabetic macular oedema in patients with type 2 diabetes Pioglitazone increases the risk of diabetic macular oedema in patients with type 2 diabetes DIABETOLOGIA, 56, S28-S28 DIABETOLOGIA, 56, S28-S28 DIABETOLOGIA, 56, S28-S28 2013/09 English Research paper, summary (international conference) Disclose to all
Y. Hamamoto, S. Honjo, Y. Kawasaki-Ogita, H. Tatsuoka, K. Fujimoto, A. Matsuoka, H. Ikeda, Y. Wada, H. Koshiyama Y. Hamamoto, S. Honjo, Y. Kawasaki-Ogita, H. Tatsuoka, K. Fujimoto, A. Matsuoka, H. Ikeda, Y. Wada, H. Koshiyama Y. Hamamoto, S. Honjo, Y. Kawasaki-Ogita, H. Tatsuoka, K. Fujimoto, A. Matsuoka, H. Ikeda, Y. Wada, H. Koshiyama Long-term effects of liraglutide on pancreatic beta cell function and glycaemic control in type 1 diabetes with residual insulin secretion Long-term effects of liraglutide on pancreatic beta cell function and glycaemic control in type 1 diabetes with residual insulin secretion Long-term effects of liraglutide on pancreatic beta cell function and glycaemic control in type 1 diabetes with residual insulin secretion DIABETOLOGIA, 56, S351-S352 DIABETOLOGIA, 56, S351-S352 DIABETOLOGIA, 56, S351-S352 2013/09 English Research paper, summary (international conference) Disclose to all
Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Kanta Fujimoto, Hisato Tatsuoka, Kanako Mori, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Kanta Fujimoto, Hisato Tatsuoka, Kanako Mori, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Kanta Fujimoto, Hisato Tatsuoka, Kanako Mori, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Enhanced Responses of Incretin Hormones to Oral Glucose Tolerance Test in Patients With Inflammatory Bowel Diseases Enhanced Responses of Incretin Hormones to Oral Glucose Tolerance Test in Patients With Inflammatory Bowel Diseases Enhanced Responses of Incretin Hormones to Oral Glucose Tolerance Test in Patients With Inflammatory Bowel Diseases DIABETES, 62, A733-A733 DIABETES, 62, A733-A733 DIABETES, 62, A733-A733 2013/07 English Research paper, summary (international conference) Disclose to all
Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Hisato Tatsuoka, Atsuko Matsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Isao Saito, Hiroyuki Koshiyama Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Hisato Tatsuoka, Atsuko Matsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Isao Saito, Hiroyuki Koshiyama Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Hisato Tatsuoka, Atsuko Matsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Isao Saito, Hiroyuki Koshiyama Pioglitazone Increases the Risk of Diabetic Macular Edema in Japanese Patients With Type 2 Diabetes Pioglitazone Increases the Risk of Diabetic Macular Edema in Japanese Patients With Type 2 Diabetes Pioglitazone Increases the Risk of Diabetic Macular Edema in Japanese Patients With Type 2 Diabetes DIABETES, 62, A154-A155 DIABETES, 62, A154-A155 DIABETES, 62, A154-A155 2013/07 English Research paper, summary (international conference) Disclose to all
Y. Hamamoto, K. Mori, S. Honjo, Y. Kawasaki, K. Fujimoto, H. Tatsuoka, A. Matsuoka, Y. Wada, H. Ikeda, H. Koshiyama Y. Hamamoto, K. Mori, S. Honjo, Y. Kawasaki, K. Fujimoto, H. Tatsuoka, A. Matsuoka, Y. Wada, H. Ikeda, H. Koshiyama Y. Hamamoto, K. Mori, S. Honjo, Y. Kawasaki, K. Fujimoto, H. Tatsuoka, A. Matsuoka, Y. Wada, H. Ikeda, H. Koshiyama One-year effects of liraglutide on pancreatic beta cell function and glycaemic control in Japanese type 1 diabetes with residual insulin secretion One-year effects of liraglutide on pancreatic beta cell function and glycaemic control in Japanese type 1 diabetes with residual insulin secretion One-year effects of liraglutide on pancreatic beta cell function and glycaemic control in Japanese type 1 diabetes with residual insulin secretion DIABETOLOGIA, 55, S300-S300 DIABETOLOGIA, 55, S300-S300 DIABETOLOGIA, 55, S300-S300 2012/10 English Research paper, summary (international conference) Disclose to all
Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Atsuko Matsuoka, Kanako Mori, Hisato Tatsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Atsuko Matsuoka, Kanako Mori, Hisato Tatsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Atsuko Matsuoka, Kanako Mori, Hisato Tatsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama Does Pioglitazone Increase Bladder Cancer Risk in Japanese Type 2 Diabetes? Does Pioglitazone Increase Bladder Cancer Risk in Japanese Type 2 Diabetes? Does Pioglitazone Increase Bladder Cancer Risk in Japanese Type 2 Diabetes? DIABETES, 61, A295-A295 DIABETES, 61, A295-A295 DIABETES, 61, A295-A295 2012/06 English Research paper, summary (international conference) Disclose to all
Sachiko Honjo, Yukiko Kawasaki, Yoshiyuki Hamamoto, Kanako Mori, Hisato Tatsuoka, Kanta Fujimoto, Atsuko Matsuoka, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Sachiko Honjo, Yukiko Kawasaki, Yoshiyuki Hamamoto, Kanako Mori, Hisato Tatsuoka, Kanta Fujimoto, Atsuko Matsuoka, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Sachiko Honjo, Yukiko Kawasaki, Yoshiyuki Hamamoto, Kanako Mori, Hisato Tatsuoka, Kanta Fujimoto, Atsuko Matsuoka, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama An Observational Prospective Study of Cancer in Japanese Subjects With Type 2 Diabetes With Special Reference to Pancreatic Cancer An Observational Prospective Study of Cancer in Japanese Subjects With Type 2 Diabetes With Special Reference to Pancreatic Cancer An Observational Prospective Study of Cancer in Japanese Subjects With Type 2 Diabetes With Special Reference to Pancreatic Cancer DIABETES, 61, A377-A377 DIABETES, 61, A377-A377 DIABETES, 61, A377-A377 2012/06 English Research paper, summary (international conference) Disclose to all
Kanako Mori, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Hisato Tatsuoka, Kanta Fujimoto, Atsuko Matsuoka, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Kanako Mori, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Hisato Tatsuoka, Kanta Fujimoto, Atsuko Matsuoka, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Kanako Mori, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Hisato Tatsuoka, Kanta Fujimoto, Atsuko Matsuoka, Hiroki Ikeda, Yoshiharu Wada, Hiroyuki Koshiyama Comparison of Liraglutide and Exenatide Evaluated by Continuous Glucose Monitoring (CGM) in Patients With Diabetes Associated With Liver Cirrhosis Comparison of Liraglutide and Exenatide Evaluated by Continuous Glucose Monitoring (CGM) in Patients With Diabetes Associated With Liver Cirrhosis Comparison of Liraglutide and Exenatide Evaluated by Continuous Glucose Monitoring (CGM) in Patients With Diabetes Associated With Liver Cirrhosis DIABETES, 61, A292-A293 DIABETES, 61, A292-A293 DIABETES, 61, A292-A293 2012/06 English Research paper, summary (international conference) Disclose to all
Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Atsuko Matsuoka, Kanako Mori, Hisato Tatsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Atsuko Matsuoka, Kanako Mori, Hisato Tatsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama Kanta Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Atsuko Matsuoka, Kanako Mori, Hisato Tatsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa, Hiroyuki Koshiyama The Changes of Bone Mineral Density in Japanese Patients With Type 2 Diabetes The Changes of Bone Mineral Density in Japanese Patients With Type 2 Diabetes The Changes of Bone Mineral Density in Japanese Patients With Type 2 Diabetes DIABETES, 61, A650-A650 DIABETES, 61, A650-A650 DIABETES, 61, A650-A650 2012/06 English Research paper, summary (international conference) Disclose to all

  • <<
  • >>
Title language: